申请人:Valentia Biopharma
公开号:EP2742974A1
公开(公告)日:2014-06-18
Phenanthrene derivatives of formula I for use as medicaments. The present invention refers to phenanthrene derivatives for use as medicaments, mainly in the prevention and/or treatment of DM1, HDL2, SCA8, DM2, SCA3, FXTAS, FTD/ALS, and SCA31. In a preferred embodiment, phenanthrene derivatives of the invention are also used as antimyotonic agents.
公式I的菲南三烯衍生物用作药物。本发明涉及用作药物的菲南三烯衍生物,主要用于预防和/或治疗DM1、HDL2、SCA8、DM2、SCA3、FXTAS、FTD/ALS和SCA31。在一个优选实施例中,本发明的菲南三烯衍生物也用作抗肌肉张力剂。